Zdrowie i gospodarka · 18/02/2011
FDA Releases Draft Guidance on Clinical Pharmacogenomics for Early Phase Clinical Studies
The FDA has made available a draft guidance document to help pharmaceutical companies and researchers assess how genetic variations impact drug efficacy and safety in early-stage clinical trials.
Source: Federal Register — Health and Human ServicesOpen original release →